6.
Fett A, Viechtbauer W, Dominguez M, Penn D, van Os J, Krabbendam L
. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. 2010; 35(3):573-88.
DOI: 10.1016/j.neubiorev.2010.07.001.
View
7.
Cowman M, Holleran L, Lonergan E, OConnor K, Birchwood M, Donohoe G
. Cognitive Predictors of Social and Occupational Functioning in Early Psychosis: A Systematic Review and Meta-analysis of Cross-Sectional and Longitudinal Data. Schizophr Bull. 2021; 47(5):1243-1253.
PMC: 8379554.
DOI: 10.1093/schbul/sbab033.
View
8.
Ritsner M, Blumenkrantz H, Dubinsky T, Dwolatzky T
. The detection of neurocognitive decline in schizophrenia using the Mindstreams Computerized Cognitive Test Battery. Schizophr Res. 2005; 82(1):39-49.
DOI: 10.1016/j.schres.2005.10.014.
View
9.
Bakker G, Vingerhoets C, Boucherie D, Caan M, Bloemen O, Eersels J
. Relationship between muscarinic M receptor binding and cognition in medication-free subjects with psychosis. Neuroimage Clin. 2018; 18:713-719.
PMC: 5857491.
DOI: 10.1016/j.nicl.2018.02.030.
View
10.
Glenthoj L, Fagerlund B, Hjorthoj C, Jepsen J, Bak N, Kristensen T
. Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?. Schizophr Res Cogn. 2017; 5:21-27.
PMC: 5514303.
DOI: 10.1016/j.scog.2016.06.004.
View
11.
Bora E, Murray R
. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis?. Schizophr Bull. 2013; 40(4):744-55.
PMC: 4059428.
DOI: 10.1093/schbul/sbt085.
View
12.
Barnett J, Robbins T, Leeson V, Sahakian B, Joyce E, Blackwell A
. Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev. 2010; 34(8):1161-77.
DOI: 10.1016/j.neubiorev.2010.01.012.
View
13.
Glenthoj L, Albert N, Fagerlund B, Kristensen T, Wenneberg C, Hjorthoj C
. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis. Schizophr Res. 2019; 210:197-202.
DOI: 10.1016/j.schres.2018.12.038.
View
14.
Chen W, Faraone S
. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet. 2000; 97(1):52-7.
DOI: 10.1002/(sici)1096-8628(200021)97:1<52::aid-ajmg7>3.0.co;2-6.
View
15.
Hedges E, See C, Si S, McGuire P, Dickson H, Kempton M
. Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis. Psychol Med. 2022; 52(11):2009-2016.
PMC: 9386433.
DOI: 10.1017/S0033291722001830.
View
16.
Levaux M, Potvin S, Sepehry A, Sablier J, Mendrek A, Stip E
. Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. Eur Psychiatry. 2007; 22(2):104-15.
DOI: 10.1016/j.eurpsy.2006.11.004.
View
17.
Green M
. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry. 1996; 153(3):321-30.
DOI: 10.1176/ajp.153.3.321.
View
18.
Pietrzak R, Olver J, Norman T, Piskulic D, Maruff P, Snyder P
. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia. J Clin Exp Neuropsychol. 2009; 31(7):848-59.
DOI: 10.1080/13803390802592458.
View
19.
Karson C, Duffy R, Eramo A, Nylander A, Offord S
. Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016; 12:57-67.
PMC: 4708960.
DOI: 10.2147/NDT.S96392.
View
20.
Koo T, Li M
. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016; 15(2):155-63.
PMC: 4913118.
DOI: 10.1016/j.jcm.2016.02.012.
View